ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

LDLT for High MELD Recipients: A Single Center Experience

S. Ganesh, M. Molinari, T. Amit, H. Christopher, H. Abhinav.

Surgery, University of Pittsburgh, Pittsburgh, PA.

Meeting: 2018 American Transplant Congress

Abstract number: 553

Keywords: Graft survival, Liver grafts, Living-related liver donors, Outcome

Session Information

Session Name: Concurrent Session: Liver: Living Donors and Partial Grafts

Session Type: Concurrent Session

Date: Tuesday, June 5, 2018

Session Time: 4:30pm-6:00pm

 Presentation Time: 5:06pm-5:18pm

Location: Room 608/609

Objectives: Living donor liver transplantation (LDLT) is underutilized in high MELD patients. Our aim was to assess the impact of high MELD score on short-term post-transplant outcomes in LDLT recipients at our center.

Methods: A total of 352 adult LDLT's were performed from 1999 to present and review of outcomes was analyzed retrospectively. Patients were grouped into low MELD<25 and high MELD ≥25 score to compare short-term outcomes.

Results: A total of 326 recipients were in low MELD group with mean MELD of (13.72 ± 4.82) and 26 in high MELD group with mean MELD of (27.92 ± 3.72), P <0.0001. There were no significant differences between the 2 groups with regards to demographics including age, gender, etiology of liver disease, BMI or incidence of HCC. The right lobe was the most commonly used graft in both groups, but the middle hepatic vein was included more commonly in the graft when it was utilized in high MELD patients. The postoperative complications were similar including PVT, and bile leak/stricture. No significant difference was noted in patient survival at 3 month (96.6% vs 96.1%, P=0.61) and at 1 year (88.3% vs 84.6%, P=0.53) between the groups. No significant difference in the graft survival at 3 months (92.9 vs 88.5%, P= 0.43) and 1 year (82.8 vs 76.9%, P= 0.43). There were also no significant differences with regards to outcomes including cause of death, and incidence of late complications including CKD, rejection, infections, PTLD, and other malignancies, between the two groups.

Conclusion: LDLT can be utilized in high MELD patients with reasonable outcomes- it is important to use an appropriate graft to match the higher acuity.

Patient Characteristics between High and low MELD Groups

CITATION INFORMATION: Ganesh S., Molinari M., Amit T., Christopher H., Abhinav H. LDLT for High MELD Recipients: A Single Center Experience Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Ganesh S, Molinari M, Amit T, Christopher H, Abhinav H. LDLT for High MELD Recipients: A Single Center Experience [abstract]. https://atcmeetingabstracts.com/abstract/ldlt-for-high-meld-recipients-a-single-center-experience/. Accessed May 13, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences